For: | Liu LP, Zhang XL, Li J. New perspectives on angiotensin-converting enzyme 2 and its related diseases. World J Diabetes 2021; 12(6): 839-854 [PMID: 34168732 DOI: 10.4239/wjd.v12.i6.839] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i6/839.htm |
Number | Citing Articles |
1 |
André Acácio Souza da Silva, Salmo Azambuja de Oliveira, Maria Agustina Battistone, Barry Thomas Hinton, Paulo Sérgio Cerri, Estela Sasso‐Cerri. hACE2 upregulation and participation of macrophages and clear cells in the immune response of epididymis to SARS‐CoV‐2 in K18‐hACE2 mice. Andrology 2024; doi: 10.1111/andr.13755
|
2 |
Emilie Narni-Mancinelli, Eric Vivier. Clues that natural killer cells help to control COVID. Nature 2021; 600(7888): 226 doi: 10.1038/d41586-021-02778-y
|
3 |
Melina Moulaeian, Saeid Ferdousmakan, Sara Banihashemi, Shadi Homayounfar, Ajay Prakash Pasupulla, Yalda Malekzadegan. Reactive oxygen species induced by SARS-CoV-2 infection can induce EMT in solid tumors: Potential role of COVID-19 in chemo-resistance and metastasis. Heliyon 2024; 10(22): e40297 doi: 10.1016/j.heliyon.2024.e40297
|
4 |
Yasmin Silva-Santos, Roberta Liberato Pagni, Thais Helena Martins Gamon, Marcela Santiago Pacheco de Azevedo, Mônica Bielavsky, Maria Laura Goussain Darido, Danielle Bruna Leal de Oliveira, Edmarcia Elisa de Souza, Carsten Wrenger, Edson Luiz Durigon, Maria Cecília Rui Luvizotto, Hans Christian Ackerman, Claudio Romero Farias Marinho, Sabrina Epiphanio, Leonardo José Moura Carvalho. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1414406
|
5 |
Nurkhodja Mukhamedov, Akmal Asrorov, Ansor Yashinov, Muzaffar Kayumov, Ahmidin Wali, Sharafitdin Mirzaakhmedov, Haji Akber Aisa, Abulimiti Yili. Synthesis and Characterisation of Chickpea Peptides-Zinc Chelates Having ACE2 Inhibitory Activity. The Protein Journal 2023; 42(5): 547 doi: 10.1007/s10930-023-10133-5
|
6 |
Ashot Avagimyan, Nana Pogosova, Lev Kakturskiy, Mohammad Sheibani, Abhiram Challa, Eugenia Kogan, Federica Fogacci, Liudmila Mikhaleva, Rositsa Vandysheva, Marianna Yakubovskaya, Andrea Faggiano, Stefano Carugo, Olga Urazova, Behnaz Jahanbin, Ekaterina Lesovaya, Srujana Polana, Kirill Kirsanov, Yasar Sattar, Artem Trofimenko, Tatiana Demura, Amene Saghazadeh, George Koliakos, Davood Shafie, Azin Alizadehasl, Arrigo Cicero, Juan Pablo Costabel, Giuseppe Biondi-Zoccai, Giulia Ottaviani, Nizal Sarrafzadegan. Doxorubicin-related cardiotoxicity: review of fundamental pathways of cardiovascular system injury. Cardiovascular Pathology 2024; 73: 107683 doi: 10.1016/j.carpath.2024.107683
|
7 |
Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, Claudia P. Campillay-Véliz, Camila Salazar-Ardiles, Andrea M. Avellaneda, Christian A. Muñoz, Angello Retamal-Díaz, Susan M. Bueno, Pablo A. González, Alexis M. Kalergis, Margarita K. Lay. New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1363572
|